Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33620 | 88 | 38.6 | 55% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2664 | 2947 | METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CANCER PREVENTION EFFICACY | Author keyword | 4 | 75% | 3% | 3 |
| 2 | INVOLUCRIN EXPRESSION | Author keyword | 4 | 75% | 3% | 3 |
| 3 | CELLULAR MOL TOXICOL PROGRAM | Address | 1 | 33% | 2% | 2 |
| 4 | DIFFERENTIATION RATE | Author keyword | 1 | 50% | 1% | 1 |
| 5 | MD ANDERSON CANCER EXPTL RADIOTHER Y | Address | 1 | 50% | 1% | 1 |
| 6 | BURLINGTON S 2147 | Address | 0 | 33% | 1% | 1 |
| 7 | CATION MOBILIZATION | Author keyword | 0 | 33% | 1% | 1 |
| 8 | MURINE L929 CELLS | Author keyword | 0 | 33% | 1% | 1 |
| 9 | MITOGEN RESPONSIVENESS | Author keyword | 0 | 17% | 1% | 1 |
| 10 | UMR5241 | Address | 0 | 17% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CANCER PREVENTION EFFICACY | 4 | 75% | 3% | 3 | Search CANCER+PREVENTION+EFFICACY | Search CANCER+PREVENTION+EFFICACY |
| 2 | INVOLUCRIN EXPRESSION | 4 | 75% | 3% | 3 | Search INVOLUCRIN+EXPRESSION | Search INVOLUCRIN+EXPRESSION |
| 3 | DIFFERENTIATION RATE | 1 | 50% | 1% | 1 | Search DIFFERENTIATION+RATE | Search DIFFERENTIATION+RATE |
| 4 | CATION MOBILIZATION | 0 | 33% | 1% | 1 | Search CATION+MOBILIZATION | Search CATION+MOBILIZATION |
| 5 | MURINE L929 CELLS | 0 | 33% | 1% | 1 | Search MURINE+L929+CELLS | Search MURINE+L929+CELLS |
| 6 | MITOGEN RESPONSIVENESS | 0 | 17% | 1% | 1 | Search MITOGEN+RESPONSIVENESS | Search MITOGEN+RESPONSIVENESS |
| 7 | 3T3T CELL | 0 | 100% | 1% | 1 | Search 3T3T+CELL | Search 3T3T+CELL |
| 8 | EGF AND FGF RECEPTORS | 0 | 100% | 1% | 1 | Search EGF+AND+FGF+RECEPTORS | Search EGF+AND+FGF+RECEPTORS |
| 9 | HUMAN DAUDI CELLS | 0 | 100% | 1% | 1 | Search HUMAN+DAUDI+CELLS | Search HUMAN+DAUDI+CELLS |
| 10 | MULTISTEP DIFFERENTIATION PROCESS | 0 | 100% | 1% | 1 | Search MULTISTEP+DIFFERENTIATION+PROCESS | Search MULTISTEP+DIFFERENTIATION+PROCESS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROADIPOCYTE GROWTH ARREST | 3 | 50% | 5% | 4 |
| 2 | NONTERMINAL DIFFERENTIATION | 1 | 40% | 2% | 2 |
| 3 | ACTIVATED RAS ONCOGENE | 1 | 25% | 2% | 2 |
| 4 | DEFECTIVE CONTROL | 0 | 15% | 2% | 2 |
| 5 | AZOXYMETHANE INDUCED TUMORS | 0 | 25% | 1% | 1 |
| 6 | INDUCED BLADDER CANCER | 0 | 20% | 1% | 1 |
| 7 | RAT PROSTATE CARCINOGENESIS | 0 | 20% | 1% | 1 |
| 8 | HUMAN PROKERATINOCYTES | 0 | 10% | 2% | 2 |
| 9 | NUCLEAR MICROENVIRONMENTS | 0 | 13% | 1% | 1 |
| 10 | STROMAL DAMAGE | 0 | 11% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Differentiation, differentiation/gene therapy and cancer | 1997 | 42 | 68 | 19% |
| MECHANISMS FOR THE INITIATION AND PROMOTION OF CARCINOGENESIS - A REVIEW AND A NEW CONCEPT | 1984 | 30 | 30 | 40% |
| DIFFERENTIATION, CANCER, AND ANTICANCER ACTIVITY | 1988 | 20 | 65 | 26% |
| Correlation of in vitro chemopreventive efficacy data from the human epidermal cell assay with animal efficacy data and clinical trial plasma levels | 2005 | 3 | 132 | 3% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CELLULAR MOL TOXICOL PROGRAM | 1 | 33% | 2.3% | 2 |
| 2 | MD ANDERSON CANCER EXPTL RADIOTHER Y | 1 | 50% | 1.1% | 1 |
| 3 | BURLINGTON S 2147 | 0 | 33% | 1.1% | 1 |
| 4 | UMR5241 | 0 | 17% | 1.1% | 1 |
| 5 | PATHOL EXPTL PATHOL SECT | 0 | 100% | 1.1% | 1 |
| 6 | UNIV VERMONT CANC | 0 | 100% | 1.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000235732 | BIOQUIM ENVELHECIMENTO DOENCAS CORRELACIONA//NPPG//BIOQUIM METABOL |
| 2 | 0.0000219113 | ADIPOGENESIS//PREADIPOCYTE//ADIPOCYTE DIFFERENTIATION |
| 3 | 0.0000170764 | RETINOBLASTOMA BINDING PROTEIN 6//SAFB//RBBP6 |
| 4 | 0.0000147574 | CELL BIOL CANC GENET//MICROCELL HYBRIDIZATION//MICROCELL FUSION |
| 5 | 0.0000131140 | MED CHILDRENS HOSP FDN//PEDIAT SURG 219 BRYANT ST//PESQUISA SOBRE TIMO |
| 6 | 0.0000126265 | PROGRESSIVE STATE SELECTION//SPONTANEOUS TRANSFORMATION//GROWTH CONSTRAINT |
| 7 | 0.0000119748 | LEUKEMIA CELL DIFFERENTIATION//DUNN OSTEOSARCOMA CELLS//LOW DOSE CYTOSINE ARABINOSIDE |
| 8 | 0.0000101813 | IMMORTALIZATION OF HUMAN CELLS//IMMORTALIZED HUMAN CELLS//MOL ENVIRONM HLTH |
| 9 | 0.0000100663 | HYDROPEROXIDE PRODUCTION//NON TPA TYPE TUMOR PROMOTER//NEOPLASM DNA |
| 10 | 0.0000097190 | NUCLEOLIN//SURFACE NUCLEOLIN//TIP ALPHA |